Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054

• Michal Kicinski,
• Alexander Eggermont,
• Stefan Suciu

Affiliations

Michal Kicinski

Department of Statistics, EORTC, Brussels, Belgium

Alexander Eggermont

Research Directorate Princess Maxima Center & Cancer Medicine University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands

Stefan Suciu

Department of Statistics, EORTC, Brussels, Belgium